1. Home
  2. LIDR vs TTRX Comparison

LIDR vs TTRX Comparison

Compare LIDR & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.65

Market Cap

118.0M

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.40

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LIDR
TTRX
Founded
2013
2015
Country
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
116.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIDR
TTRX
Price
$1.65
$3.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$8.00
AVG Volume (30 Days)
669.7K
26.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.07
N/A
Revenue Next Year
$2,660.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$2.57
52 Week High
$6.44
$5.98

Technical Indicators

Market Signals
Indicator
LIDR
TTRX
Relative Strength Index (RSI) 42.92 30.59
Support Level $1.60 $3.55
Resistance Level $1.71 $3.63
Average True Range (ATR) 0.11 0.26
MACD 0.02 -0.12
Stochastic Oscillator 59.40 0.00

Price Performance

Historical Comparison
LIDR
TTRX

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: